Johnson Philip L has filed 7 insider transactions across 1 company since March 2024.
Most recent transaction: a tax payment of 2615 shares of Jazz Pharmaceuticals plc ($JAZZ) on March 05, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | F | Ordinary Shares | 2615 | $188.69 | 59,608.0000 | 61,606,000 | 4.20% | 0.00% |
| Feb. 26, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | A | Ordinary Shares | 11857 | $0.00 | 62,223.0000 | 61,606,000 | 23.54% | 0.02% |
| March 5, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | D | Ordinary Shares | 1149 | $138.95 | 50,060.0000 | 66,007,000 | 2.24% | 0.00% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | A | Ordinary Shares | 7704 | $0.00 | 51,209.0000 | 66,007,000 | 17.71% | 0.01% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | A | Ordinary Shares | 15407 | $0.00 | 43,505.0000 | 66,007,000 | 54.83% | 0.02% |
| March 1, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | A | Ordinary Shares | 15932 | $0.00 | 15,932.0000 | 72,066,000 | 9999.99% | 0.02% |
| March 1, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Johnson Philip L | EVP & Chief Financial Officer | P | Ordinary Shares | 12000 | $119.65 | 27,932.0000 | 72,066,000 | 75.32% | 0.02% |